Company intelligence / Profile preview
Shanxi Pikang Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Shanxi Pikang Pharmaceutical develops and manufactures herbal medicines, with a primary focus on nervous system and cardiovascular diseases. Its lead product, Zhi Xiong Capsule, is in Phase 2 clinical development for the treatment of ischemic stroke. The company appears to have at least one approved product and an active clinical pipeline focused on traditional Chinese medicine approaches to major disease areas.[1][3] No detailed published results from clinical trials are available.
- Therapeutic areas
- NeurologyCardiovascular
- Modalities
- Herbal medicine
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Shanxi Pikang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanxi Pikang Pharmaceutical.